Drawing for NAVIGATING THE NEW HEALTH

USPTO serial 77798327

NAVIGATING THE NEW HEALTH

Reviewed by CopyMark Law Group

Reg. 4042560Status 710
Filing date
Status date
Registration date
Oct 18, 2011
Examiner
TOOLEY, DAVID E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NAVIGATING THE NEW HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arlene D. Hanks

ARLENE D. HANKS Moore & Van Allen PLLC3015 Carrington Mill BoulevardSuite 400Morrisville, NC 27560

Goods and services

ClassDescriptionStatusFirst use
036Providing financial services in the pharmaceutical, biotechnology and life sciences fields, namely, providing financing to pharmaceutical, biotechnology and life sciences companies for product development and commercialization, making acquisitions of products and product rights of and investments in pharmaceutical, biotechnology and life sciences companies; capital funding services to pharmaceutical, biotechnology and life sciences companies for the development and commercialization of new products, management of product portfolios, prioritization of financial resources and achievement of financial objectives; and providing financial consultation in connection with all of the aboveSECTION 8 - CANCELLEDJan 20, 2010
041Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewithSECTION 8 - CANCELLEDJan 20, 2010
042Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; research and development services with respect to the scientific aspects of healthcare policy; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for othersSECTION 8 - CANCELLEDJan 20, 2010
044Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medicine and pharmaceuticalsSECTION 8 - CANCELLEDJan 20, 2010
045Regulatory compliance research in the development and testing of drugs, devices, biologics and methodologies used in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; regulatory compliance consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory compliance audits for others to ensure the accuracy and validity of information developed in the research and testing of drugs, devices and biologics in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation procedures, namely, reviewing standards and practices to assure compliance with clinical trial regulations; providing regulatory information, namely, providing information regarding the examination and approval process of pharmaceutical, biotechnical, medical and diagnostic products and methodologies by governmental regulatory bodies; providing regulatory implementation services relating to the development and validation of drugs, devices and biologics, namely, assisting others in implementing procedures that comply with regulatory requirementsSECTION 8 - CANCELLEDJan 20, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 25, 2018C8..CANCELLED SEC. 8 (6-YR)—
Oct 19, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 18, 2016REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 12, 2016ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 27, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 20, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 17, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 18, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 15, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Sep 14, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 9, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 5, 2011IUAFUSE AMENDMENT FILED—
Aug 5, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 5, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 8, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 14, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 14, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 9, 2010ALIEASSIGNED TO LIE—
Oct 28, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 26, 2010ATRVATTORNEY REVIEW COMPLETED—
Oct 22, 2010DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 21, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 23, 2010DRRRDIVISIONAL REQUEST RECEIVED—
Sep 23, 2010ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 5, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 5, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 5, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 12, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 12, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 11, 2009DOCKASSIGNED TO EXAMINER—
Aug 10, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 10, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance